SciHub
文献互助
期刊查询
一搜即达
科研导航
即时热点
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
已入深夜,您辛苦了!由于当前在线用户较少,发布求助请尽量完整的填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!祝你早点完成任务,早点休息,好梦!
也许飞鸟能到那个木屋
Lv1
100 积分
2022-10-21 加入
最近求助
最近应助
互助留言
Targeted therapy in glomerular diseases
3个月前
已完结
Treatment of primary Sjögren’s syndrome with ianalumab (VAY736) targeting B cells by BAFF receptor blockade coupled with enhanced, antibody-dependent cellular cytotoxicity
4个月前
已完结
Assessments of fatigue and disease activity in patients with systemic lupus erythematosus enrolled in the Phase 2 clinical trial with blisibimod
4个月前
已完结
Efficacy and Safety of Belimumab in Patients With Lupus Nephritis: Subgroup Analyses of a Phase 3 Randomized Trial in the East Asian Population
4个月前
已完结
Efficacy and safety of belimumab in patients with lupus nephritis: a real-world retrospective observational study
4个月前
已完结
Belimumab for the treatment of pediatric patients with lupus nephritis
4个月前
已完结
Belimumab as Add-on Therapy in Lupus Nephritis
4个月前
已完结
A patient with refractory proliferative lupus nephritis treated with telitacicept: A case report
4个月前
已完结
Accelerating the Depletion of Circulating Anti-Phospholipase A<sub>2</sub> Receptor Antibodies in Patients with Severe Membranous Nephropathy: Preliminary Findings with Double Filtration Plasmapheresis and Ofatumumab
4个月前
已完结
Ofatumumab for multirelapsing membranous nephropathy complicated by rituximab-induced serum-sickness
4个月前
已完结
没有进行任何应助
没有进行任何互助留言
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论